Neonatal Vancomycin Trial (NeoVanc)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02790996 |
|
Recruitment Status :
Recruiting
First Posted : June 6, 2016
Last Update Posted : June 29, 2018
|
Sponsor:
PENTA Foundation
Collaborators:
St George's, University of London
Institut National de la Santé Et de la Recherche Médicale, France
University of Tartu
Consorzio per Valutazioni Biologiche e Farmacologiche
University of Liverpool
Therakind limited
Bambino Gesù Hospital and Research Institute
Servicio Madrileño de Salud, Madrid, Spain
Aristotle University Of Thessaloniki
University of Edinburgh
SYNAPSE Research Management Partners S.L
European Commission
Information provided by (Responsible Party):
PENTA Foundation
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 1, 2018 |
| Estimated Study Completion Date : | February 1, 2019 |